img

Global Valsartan and Amlodipine Tablets Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Valsartan and Amlodipine Tablets Market Insights, Forecast to 2034

Drugs for the treatment of essential hypertension
Global Valsartan and Amlodipine Tablets market is expected to reach to US$ 451.5 million in 2024, with a positive growth of %, compared with US$ 420 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Valsartan and Amlodipine Tablets industry is evaluated to reach US$ 696.8 million in 2029. The CAGR will be 7.5% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Valsartan and Amlodipine Tablets market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Valsartan and Amlodipine Tablets market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Baiao Pharma
Novartis Pharma
Brilliant Pharma
Hengrui Pharma
Huahai Pharma
Lepu Pharma
Wangao Pharma
Juventas
Huaxin Pharma
HXP
KPC
Miaoyinchun
Segment by Type
Valsartan and Amlodipine Tablets(Ⅰ)
Valsartan and Amlodipine Tablets(II)

Segment by Application


Hospital
Clinic
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Valsartan and Amlodipine Tablets plant distribution, commercial date of Valsartan and Amlodipine Tablets, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Valsartan and Amlodipine Tablets introduction, etc. Valsartan and Amlodipine Tablets Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Valsartan and Amlodipine Tablets
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Valsartan and Amlodipine Tablets Product Introduction
1.2 Market by Type
1.2.1 Global Valsartan and Amlodipine Tablets Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Valsartan and Amlodipine Tablets(Ⅰ)
1.2.3 Valsartan and Amlodipine Tablets(II)
1.3 Market by Application
1.3.1 Global Valsartan and Amlodipine Tablets Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Valsartan and Amlodipine Tablets Sales Estimates and Forecasts 2018-2029
2.2 Global Valsartan and Amlodipine Tablets Revenue by Region
2.2.1 Global Valsartan and Amlodipine Tablets Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Valsartan and Amlodipine Tablets Revenue by Region (2018-2024)
2.2.3 Global Valsartan and Amlodipine Tablets Revenue by Region (2024-2029)
2.2.4 Global Valsartan and Amlodipine Tablets Revenue Market Share by Region (2018-2029)
2.3 Global Valsartan and Amlodipine Tablets Sales Estimates and Forecasts 2018-2029
2.4 Global Valsartan and Amlodipine Tablets Sales by Region
2.4.1 Global Valsartan and Amlodipine Tablets Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Valsartan and Amlodipine Tablets Sales by Region (2018-2024)
2.4.3 Global Valsartan and Amlodipine Tablets Sales by Region (2024-2029)
2.4.4 Global Valsartan and Amlodipine Tablets Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Valsartan and Amlodipine Tablets Sales by Manufacturers
3.1.1 Global Valsartan and Amlodipine Tablets Sales by Manufacturers (2018-2024)
3.1.2 Global Valsartan and Amlodipine Tablets Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Valsartan and Amlodipine Tablets in 2022
3.2 Global Valsartan and Amlodipine Tablets Revenue by Manufacturers
3.2.1 Global Valsartan and Amlodipine Tablets Revenue by Manufacturers (2018-2024)
3.2.2 Global Valsartan and Amlodipine Tablets Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Valsartan and Amlodipine Tablets Revenue in 2022
3.3 Global Key Players of Valsartan and Amlodipine Tablets, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Valsartan and Amlodipine Tablets Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Valsartan and Amlodipine Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Valsartan and Amlodipine Tablets, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Valsartan and Amlodipine Tablets, Product Offered and Application
3.8 Global Key Manufacturers of Valsartan and Amlodipine Tablets, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Valsartan and Amlodipine Tablets Sales by Type
4.1.1 Global Valsartan and Amlodipine Tablets Historical Sales by Type (2018-2024)
4.1.2 Global Valsartan and Amlodipine Tablets Forecasted Sales by Type (2024-2029)
4.1.3 Global Valsartan and Amlodipine Tablets Sales Market Share by Type (2018-2029)
4.2 Global Valsartan and Amlodipine Tablets Revenue by Type
4.2.1 Global Valsartan and Amlodipine Tablets Historical Revenue by Type (2018-2024)
4.2.2 Global Valsartan and Amlodipine Tablets Forecasted Revenue by Type (2024-2029)
4.2.3 Global Valsartan and Amlodipine Tablets Revenue Market Share by Type (2018-2029)
4.3 Global Valsartan and Amlodipine Tablets Price by Type
4.3.1 Global Valsartan and Amlodipine Tablets Price by Type (2018-2024)
4.3.2 Global Valsartan and Amlodipine Tablets Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Valsartan and Amlodipine Tablets Sales by Application
5.1.1 Global Valsartan and Amlodipine Tablets Historical Sales by Application (2018-2024)
5.1.2 Global Valsartan and Amlodipine Tablets Forecasted Sales by Application (2024-2029)
5.1.3 Global Valsartan and Amlodipine Tablets Sales Market Share by Application (2018-2029)
5.2 Global Valsartan and Amlodipine Tablets Revenue by Application
5.2.1 Global Valsartan and Amlodipine Tablets Historical Revenue by Application (2018-2024)
5.2.2 Global Valsartan and Amlodipine Tablets Forecasted Revenue by Application (2024-2029)
5.2.3 Global Valsartan and Amlodipine Tablets Revenue Market Share by Application (2018-2029)
5.3 Global Valsartan and Amlodipine Tablets Price by Application
5.3.1 Global Valsartan and Amlodipine Tablets Price by Application (2018-2024)
5.3.2 Global Valsartan and Amlodipine Tablets Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Valsartan and Amlodipine Tablets Market Size by Type
6.1.1 US & Canada Valsartan and Amlodipine Tablets Sales by Type (2018-2029)
6.1.2 US & Canada Valsartan and Amlodipine Tablets Revenue by Type (2018-2029)
6.2 US & Canada Valsartan and Amlodipine Tablets Market Size by Application
6.2.1 US & Canada Valsartan and Amlodipine Tablets Sales by Application (2018-2029)
6.2.2 US & Canada Valsartan and Amlodipine Tablets Revenue by Application (2018-2029)
6.3 US & Canada Valsartan and Amlodipine Tablets Market Size by Country
6.3.1 US & Canada Valsartan and Amlodipine Tablets Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Valsartan and Amlodipine Tablets Sales by Country (2018-2029)
6.3.3 US & Canada Valsartan and Amlodipine Tablets Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Valsartan and Amlodipine Tablets Market Size by Type
7.1.1 Europe Valsartan and Amlodipine Tablets Sales by Type (2018-2029)
7.1.2 Europe Valsartan and Amlodipine Tablets Revenue by Type (2018-2029)
7.2 Europe Valsartan and Amlodipine Tablets Market Size by Application
7.2.1 Europe Valsartan and Amlodipine Tablets Sales by Application (2018-2029)
7.2.2 Europe Valsartan and Amlodipine Tablets Revenue by Application (2018-2029)
7.3 Europe Valsartan and Amlodipine Tablets Market Size by Country
7.3.1 Europe Valsartan and Amlodipine Tablets Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Valsartan and Amlodipine Tablets Sales by Country (2018-2029)
7.3.3 Europe Valsartan and Amlodipine Tablets Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Valsartan and Amlodipine Tablets Market Size
8.1.1 China Valsartan and Amlodipine Tablets Sales (2018-2029)
8.1.2 China Valsartan and Amlodipine Tablets Revenue (2018-2029)
8.2 China Valsartan and Amlodipine Tablets Market Size by Application
8.2.1 China Valsartan and Amlodipine Tablets Sales by Application (2018-2029)
8.2.2 China Valsartan and Amlodipine Tablets Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Valsartan and Amlodipine Tablets Market Size by Type
9.1.1 Asia Valsartan and Amlodipine Tablets Sales by Type (2018-2029)
9.1.2 Asia Valsartan and Amlodipine Tablets Revenue by Type (2018-2029)
9.2 Asia Valsartan and Amlodipine Tablets Market Size by Application
9.2.1 Asia Valsartan and Amlodipine Tablets Sales by Application (2018-2029)
9.2.2 Asia Valsartan and Amlodipine Tablets Revenue by Application (2018-2029)
9.3 Asia Valsartan and Amlodipine Tablets Sales by Region
9.3.1 Asia Valsartan and Amlodipine Tablets Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Valsartan and Amlodipine Tablets Revenue by Region (2018-2029)
9.3.3 Asia Valsartan and Amlodipine Tablets Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Market Size by Type
10.1.1 Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Market Size by Application
10.2.1 Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Sales by Country
10.3.1 Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Baiao Pharma
11.1.1 Baiao Pharma Company Information
11.1.2 Baiao Pharma Overview
11.1.3 Baiao Pharma Valsartan and Amlodipine Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Baiao Pharma Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Baiao Pharma Recent Developments
11.2 Novartis Pharma
11.2.1 Novartis Pharma Company Information
11.2.2 Novartis Pharma Overview
11.2.3 Novartis Pharma Valsartan and Amlodipine Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Novartis Pharma Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis Pharma Recent Developments
11.3 Brilliant Pharma
11.3.1 Brilliant Pharma Company Information
11.3.2 Brilliant Pharma Overview
11.3.3 Brilliant Pharma Valsartan and Amlodipine Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Brilliant Pharma Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Brilliant Pharma Recent Developments
11.4 Hengrui Pharma
11.4.1 Hengrui Pharma Company Information
11.4.2 Hengrui Pharma Overview
11.4.3 Hengrui Pharma Valsartan and Amlodipine Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Hengrui Pharma Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Hengrui Pharma Recent Developments
11.5 Huahai Pharma
11.5.1 Huahai Pharma Company Information
11.5.2 Huahai Pharma Overview
11.5.3 Huahai Pharma Valsartan and Amlodipine Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Huahai Pharma Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Huahai Pharma Recent Developments
11.6 Lepu Pharma
11.6.1 Lepu Pharma Company Information
11.6.2 Lepu Pharma Overview
11.6.3 Lepu Pharma Valsartan and Amlodipine Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Lepu Pharma Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lepu Pharma Recent Developments
11.7 Wangao Pharma
11.7.1 Wangao Pharma Company Information
11.7.2 Wangao Pharma Overview
11.7.3 Wangao Pharma Valsartan and Amlodipine Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Wangao Pharma Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Wangao Pharma Recent Developments
11.8 Juventas
11.8.1 Juventas Company Information
11.8.2 Juventas Overview
11.8.3 Juventas Valsartan and Amlodipine Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Juventas Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Juventas Recent Developments
11.9 Huaxin Pharma
11.9.1 Huaxin Pharma Company Information
11.9.2 Huaxin Pharma Overview
11.9.3 Huaxin Pharma Valsartan and Amlodipine Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Huaxin Pharma Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Huaxin Pharma Recent Developments
11.10 HXP
11.10.1 HXP Company Information
11.10.2 HXP Overview
11.10.3 HXP Valsartan and Amlodipine Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 HXP Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 HXP Recent Developments
11.11 KPC
11.11.1 KPC Company Information
11.11.2 KPC Overview
11.11.3 KPC Valsartan and Amlodipine Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 KPC Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 KPC Recent Developments
11.12 Miaoyinchun
11.12.1 Miaoyinchun Company Information
11.12.2 Miaoyinchun Overview
11.12.3 Miaoyinchun Valsartan and Amlodipine Tablets Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Miaoyinchun Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Miaoyinchun Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Valsartan and Amlodipine Tablets Industry Chain Analysis
12.2 Valsartan and Amlodipine Tablets Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Valsartan and Amlodipine Tablets Production Mode & Process
12.4 Valsartan and Amlodipine Tablets Sales and Marketing
12.4.1 Valsartan and Amlodipine Tablets Sales Channels
12.4.2 Valsartan and Amlodipine Tablets Distributors
12.5 Valsartan and Amlodipine Tablets Customers
13 Market Dynamics
13.1 Valsartan and Amlodipine Tablets Industry Trends
13.2 Valsartan and Amlodipine Tablets Market Drivers
13.3 Valsartan and Amlodipine Tablets Market Challenges
13.4 Valsartan and Amlodipine Tablets Market Restraints
14 Key Findings in The Global Valsartan and Amlodipine Tablets Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Valsartan and Amlodipine Tablets Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Valsartan and Amlodipine Tablets(Ⅰ)
Table 3. Major Manufacturers of Valsartan and Amlodipine Tablets(II)
Table 4. Global Valsartan and Amlodipine Tablets Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Valsartan and Amlodipine Tablets Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Valsartan and Amlodipine Tablets Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Valsartan and Amlodipine Tablets Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Valsartan and Amlodipine Tablets Revenue Market Share by Region (2018-2024)
Table 9. Global Valsartan and Amlodipine Tablets Revenue Market Share by Region (2024-2029)
Table 10. Global Valsartan and Amlodipine Tablets Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Valsartan and Amlodipine Tablets Sales by Region (2018-2024) & (Box)
Table 12. Global Valsartan and Amlodipine Tablets Sales by Region (2024-2029) & (Box)
Table 13. Global Valsartan and Amlodipine Tablets Sales Market Share by Region (2018-2024)
Table 14. Global Valsartan and Amlodipine Tablets Sales Market Share by Region (2024-2029)
Table 15. Global Valsartan and Amlodipine Tablets Sales by Manufacturers (2018-2024) & (Box)
Table 16. Global Valsartan and Amlodipine Tablets Sales Share by Manufacturers (2018-2024)
Table 17. Global Valsartan and Amlodipine Tablets Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Valsartan and Amlodipine Tablets Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Valsartan and Amlodipine Tablets, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Valsartan and Amlodipine Tablets Price by Manufacturers 2018-2024 (US$/Box)
Table 21. Global Valsartan and Amlodipine Tablets Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Valsartan and Amlodipine Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Valsartan and Amlodipine Tablets as of 2022)
Table 23. Global Key Manufacturers of Valsartan and Amlodipine Tablets, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Valsartan and Amlodipine Tablets, Product Offered and Application
Table 25. Global Key Manufacturers of Valsartan and Amlodipine Tablets, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Valsartan and Amlodipine Tablets Sales by Type (2018-2024) & (Box)
Table 28. Global Valsartan and Amlodipine Tablets Sales by Type (2024-2029) & (Box)
Table 29. Global Valsartan and Amlodipine Tablets Sales Share by Type (2018-2024)
Table 30. Global Valsartan and Amlodipine Tablets Sales Share by Type (2024-2029)
Table 31. Global Valsartan and Amlodipine Tablets Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Valsartan and Amlodipine Tablets Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Valsartan and Amlodipine Tablets Revenue Share by Type (2018-2024)
Table 34. Global Valsartan and Amlodipine Tablets Revenue Share by Type (2024-2029)
Table 35. Valsartan and Amlodipine Tablets Price by Type (2018-2024) & (US$/Box)
Table 36. Global Valsartan and Amlodipine Tablets Price Forecast by Type (2024-2029) & (US$/Box)
Table 37. Global Valsartan and Amlodipine Tablets Sales by Application (2018-2024) & (Box)
Table 38. Global Valsartan and Amlodipine Tablets Sales by Application (2024-2029) & (Box)
Table 39. Global Valsartan and Amlodipine Tablets Sales Share by Application (2018-2024)
Table 40. Global Valsartan and Amlodipine Tablets Sales Share by Application (2024-2029)
Table 41. Global Valsartan and Amlodipine Tablets Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Valsartan and Amlodipine Tablets Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Valsartan and Amlodipine Tablets Revenue Share by Application (2018-2024)
Table 44. Global Valsartan and Amlodipine Tablets Revenue Share by Application (2024-2029)
Table 45. Valsartan and Amlodipine Tablets Price by Application (2018-2024) & (US$/Box)
Table 46. Global Valsartan and Amlodipine Tablets Price Forecast by Application (2024-2029) & (US$/Box)
Table 47. US & Canada Valsartan and Amlodipine Tablets Sales by Type (2018-2024) & (Box)
Table 48. US & Canada Valsartan and Amlodipine Tablets Sales by Type (2024-2029) & (Box)
Table 49. US & Canada Valsartan and Amlodipine Tablets Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Valsartan and Amlodipine Tablets Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Valsartan and Amlodipine Tablets Sales by Application (2018-2024) & (Box)
Table 52. US & Canada Valsartan and Amlodipine Tablets Sales by Application (2024-2029) & (Box)
Table 53. US & Canada Valsartan and Amlodipine Tablets Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Valsartan and Amlodipine Tablets Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Valsartan and Amlodipine Tablets Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Valsartan and Amlodipine Tablets Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Valsartan and Amlodipine Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Valsartan and Amlodipine Tablets Sales by Country (2018-2024) & (Box)
Table 59. US & Canada Valsartan and Amlodipine Tablets Sales by Country (2024-2029) & (Box)
Table 60. Europe Valsartan and Amlodipine Tablets Sales by Type (2018-2024) & (Box)
Table 61. Europe Valsartan and Amlodipine Tablets Sales by Type (2024-2029) & (Box)
Table 62. Europe Valsartan and Amlodipine Tablets Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Valsartan and Amlodipine Tablets Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Valsartan and Amlodipine Tablets Sales by Application (2018-2024) & (Box)
Table 65. Europe Valsartan and Amlodipine Tablets Sales by Application (2024-2029) & (Box)
Table 66. Europe Valsartan and Amlodipine Tablets Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Valsartan and Amlodipine Tablets Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Valsartan and Amlodipine Tablets Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Valsartan and Amlodipine Tablets Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Valsartan and Amlodipine Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Valsartan and Amlodipine Tablets Sales by Country (2018-2024) & (Box)
Table 72. Europe Valsartan and Amlodipine Tablets Sales by Country (2024-2029) & (Box)
Table 73. China Valsartan and Amlodipine Tablets Sales by Type (2018-2024) & (Box)
Table 74. China Valsartan and Amlodipine Tablets Sales by Type (2024-2029) & (Box)
Table 75. China Valsartan and Amlodipine Tablets Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Valsartan and Amlodipine Tablets Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Valsartan and Amlodipine Tablets Sales by Application (2018-2024) & (Box)
Table 78. China Valsartan and Amlodipine Tablets Sales by Application (2024-2029) & (Box)
Table 79. China Valsartan and Amlodipine Tablets Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Valsartan and Amlodipine Tablets Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Valsartan and Amlodipine Tablets Sales by Type (2018-2024) & (Box)
Table 82. Asia Valsartan and Amlodipine Tablets Sales by Type (2024-2029) & (Box)
Table 83. Asia Valsartan and Amlodipine Tablets Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Valsartan and Amlodipine Tablets Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Valsartan and Amlodipine Tablets Sales by Application (2018-2024) & (Box)
Table 86. Asia Valsartan and Amlodipine Tablets Sales by Application (2024-2029) & (Box)
Table 87. Asia Valsartan and Amlodipine Tablets Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Valsartan and Amlodipine Tablets Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Valsartan and Amlodipine Tablets Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Valsartan and Amlodipine Tablets Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Valsartan and Amlodipine Tablets Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Valsartan and Amlodipine Tablets Sales by Region (2018-2024) & (Box)
Table 93. Asia Valsartan and Amlodipine Tablets Sales by Region (2024-2029) & (Box)
Table 94. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Sales by Type (2018-2024) & (Box)
Table 95. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Sales by Type (2024-2029) & (Box)
Table 96. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Sales by Application (2018-2024) & (Box)
Table 99. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Sales by Application (2024-2029) & (Box)
Table 100. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Sales by Country (2018-2024) & (Box)
Table 106. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Sales by Country (2024-2029) & (Box)
Table 107. Baiao Pharma Company Information
Table 108. Baiao Pharma Description and Major Businesses
Table 109. Baiao Pharma Valsartan and Amlodipine Tablets Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 110. Baiao Pharma Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Baiao Pharma Recent Developments
Table 112. Novartis Pharma Company Information
Table 113. Novartis Pharma Description and Major Businesses
Table 114. Novartis Pharma Valsartan and Amlodipine Tablets Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 115. Novartis Pharma Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Novartis Pharma Recent Developments
Table 117. Brilliant Pharma Company Information
Table 118. Brilliant Pharma Description and Major Businesses
Table 119. Brilliant Pharma Valsartan and Amlodipine Tablets Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 120. Brilliant Pharma Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Brilliant Pharma Recent Developments
Table 122. Hengrui Pharma Company Information
Table 123. Hengrui Pharma Description and Major Businesses
Table 124. Hengrui Pharma Valsartan and Amlodipine Tablets Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 125. Hengrui Pharma Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Hengrui Pharma Recent Developments
Table 127. Huahai Pharma Company Information
Table 128. Huahai Pharma Description and Major Businesses
Table 129. Huahai Pharma Valsartan and Amlodipine Tablets Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 130. Huahai Pharma Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Huahai Pharma Recent Developments
Table 132. Lepu Pharma Company Information
Table 133. Lepu Pharma Description and Major Businesses
Table 134. Lepu Pharma Valsartan and Amlodipine Tablets Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 135. Lepu Pharma Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Lepu Pharma Recent Developments
Table 137. Wangao Pharma Company Information
Table 138. Wangao Pharma Description and Major Businesses
Table 139. Wangao Pharma Valsartan and Amlodipine Tablets Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 140. Wangao Pharma Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Wangao Pharma Recent Developments
Table 142. Juventas Company Information
Table 143. Juventas Description and Major Businesses
Table 144. Juventas Valsartan and Amlodipine Tablets Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 145. Juventas Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Juventas Recent Developments
Table 147. Huaxin Pharma Company Information
Table 148. Huaxin Pharma Description and Major Businesses
Table 149. Huaxin Pharma Valsartan and Amlodipine Tablets Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 150. Huaxin Pharma Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Huaxin Pharma Recent Developments
Table 152. HXP Company Information
Table 153. HXP Description and Major Businesses
Table 154. HXP Valsartan and Amlodipine Tablets Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 155. HXP Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. HXP Recent Developments
Table 157. KPC Company Information
Table 158. KPC Description and Major Businesses
Table 159. KPC Valsartan and Amlodipine Tablets Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 160. KPC Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. KPC Recent Developments
Table 162. Miaoyinchun Company Information
Table 163. Miaoyinchun Description and Major Businesses
Table 164. Miaoyinchun Valsartan and Amlodipine Tablets Sales (Box), Revenue (US$ Million), Price (US$/Box) and Gross Margin (2018-2024)
Table 165. Miaoyinchun Valsartan and Amlodipine Tablets Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Miaoyinchun Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Valsartan and Amlodipine Tablets Distributors List
Table 170. Valsartan and Amlodipine Tablets Customers List
Table 171. Valsartan and Amlodipine Tablets Market Trends
Table 172. Valsartan and Amlodipine Tablets Market Drivers
Table 173. Valsartan and Amlodipine Tablets Market Challenges
Table 174. Valsartan and Amlodipine Tablets Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Valsartan and Amlodipine Tablets Product Picture
Figure 2. Global Valsartan and Amlodipine Tablets Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Valsartan and Amlodipine Tablets Market Share by Type in 2022 & 2029
Figure 4. Valsartan and Amlodipine Tablets(Ⅰ) Product Picture
Figure 5. Valsartan and Amlodipine Tablets(II) Product Picture
Figure 6. Global Valsartan and Amlodipine Tablets Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Valsartan and Amlodipine Tablets Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Valsartan and Amlodipine Tablets Report Years Considered
Figure 12. Global Valsartan and Amlodipine Tablets Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Valsartan and Amlodipine Tablets Revenue 2018-2029 (US$ Million)
Figure 14. Global Valsartan and Amlodipine Tablets Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Valsartan and Amlodipine Tablets Revenue Market Share by Region (2018-2029)
Figure 16. Global Valsartan and Amlodipine Tablets Sales 2018-2029 ((Box)
Figure 17. Global Valsartan and Amlodipine Tablets Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Valsartan and Amlodipine Tablets Sales YoY (2018-2029) & (Box)
Figure 19. US & Canada Valsartan and Amlodipine Tablets Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Valsartan and Amlodipine Tablets Sales YoY (2018-2029) & (Box)
Figure 21. Europe Valsartan and Amlodipine Tablets Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Valsartan and Amlodipine Tablets Sales YoY (2018-2029) & (Box)
Figure 23. China Valsartan and Amlodipine Tablets Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Valsartan and Amlodipine Tablets Sales YoY (2018-2029) & (Box)
Figure 25. Asia (excluding China) Valsartan and Amlodipine Tablets Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Sales YoY (2018-2029) & (Box)
Figure 27. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Valsartan and Amlodipine Tablets Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Valsartan and Amlodipine Tablets in the World: Market Share by Valsartan and Amlodipine Tablets Revenue in 2022
Figure 30. Global Valsartan and Amlodipine Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Valsartan and Amlodipine Tablets Sales Market Share by Type (2018-2029)
Figure 32. Global Valsartan and Amlodipine Tablets Revenue Market Share by Type (2018-2029)
Figure 33. Global Valsartan and Amlodipine Tablets Sales Market Share by Application (2018-2029)
Figure 34. Global Valsartan and Amlodipine Tablets Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Valsartan and Amlodipine Tablets Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Valsartan and Amlodipine Tablets Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Valsartan and Amlodipine Tablets Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Valsartan and Amlodipine Tablets Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Valsartan and Amlodipine Tablets Revenue Share by Country (2018-2029)
Figure 40. US & Canada Valsartan and Amlodipine Tablets Sales Share by Country (2018-2029)
Figure 41. U.S. Valsartan and Amlodipine Tablets Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Valsartan and Amlodipine Tablets Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Valsartan and Amlodipine Tablets Sales Market Share by Type (2018-2029)
Figure 44. Europe Valsartan and Amlodipine Tablets Revenue Market Share by Type (2018-2029)
Figure 45. Europe Valsartan and Amlodipine Tablets Sales Market Share by Application (2018-2029)
Figure 46. Europe Valsartan and Amlodipine Tablets Revenue Market Share by Application (2018-2029)
Figure 47. Europe Valsartan and Amlodipine Tablets Revenue Share by Country (2018-2029)
Figure 48. Europe Valsartan and Amlodipine Tablets Sales Share by Country (2018-2029)
Figure 49. Germany Valsartan and Amlodipine Tablets Revenue (2018-2029) & (US$ Million)
Figure 50. France Valsartan and Amlodipine Tablets Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Valsartan and Amlodipine Tablets Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Valsartan and Amlodipine Tablets Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Valsartan and Amlodipine Tablets Revenue (2018-2029) & (US$ Million)
Figure 54. China Valsartan and Amlodipine Tablets Sales Market Share by Type (2018-2029)
Figure 55. China Valsartan and Amlodipine Tablets Revenue Market Share by Type (2018-2029)
Figure 56. China Valsartan and Amlodipine Tablets Sales Market Share by Application (2018-2029)
Figure 57. China Valsartan and Amlodipine Tablets Revenue Market Share by Application (2018-2029)
Figure 58. Asia Valsartan and Amlodipine Tablets Sales Market Share by Type (2018-2029)
Figure 59. Asia Valsartan and Amlodipine Tablets Revenue Market Share by Type (2018-2029)
Figure 60. Asia Valsartan and Amlodipine Tablets Sales Market Share by Application (2018-2029)
Figure 61. Asia Valsartan and Amlodipine Tablets Revenue Market Share by Application (2018-2029)
Figure 62. Asia Valsartan and Amlodipine Tablets Revenue Share by Region (2018-2029)
Figure 63. Asia Valsartan and Amlodipine Tablets Sales Share by Region (2018-2029)
Figure 64. Japan Valsartan and Amlodipine Tablets Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Valsartan and Amlodipine Tablets Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Valsartan and Amlodipine Tablets Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Valsartan and Amlodipine Tablets Revenue (2018-2029) & (US$ Million)
Figure 68. India Valsartan and Amlodipine Tablets Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Valsartan and Amlodipine Tablets Sales Share by Country (2018-2029)
Figure 75. Brazil Valsartan and Amlodipine Tablets Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Valsartan and Amlodipine Tablets Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Valsartan and Amlodipine Tablets Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Valsartan and Amlodipine Tablets Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Valsartan and Amlodipine Tablets Revenue (2018-2029) & (US$ Million)
Figure 80. Valsartan and Amlodipine Tablets Value Chain
Figure 81. Valsartan and Amlodipine Tablets Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed